Skip to content

EZI Biolab: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

EZI Biolab

BE 0500.516.337
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€20,694
2024 · -€5,617-€15,077
Equity
€152,455
2024 · €173,149-€20,694
Cash
€51,906
2024 · €57,002-€5,095
Balance sheet total
€599,741
2024 · €648,470-€48,728

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€35,294

    down €35,294 (-7.2%), from €488,756 to €453,462

  • Receivables within one year -€30,059

    down €30,059 (-56.6%), from €53,146 to €23,086

  • Stocks and contracts +€22,610

    up €22,610 (+50.6%), from €44,689 to €67,299

Equity and liabilities
  • Debts after one year -€32,771

    down €32,771 (-9.7%), from €336,754 to €303,983

  • Profit (loss) carried forward -€20,694

    down €20,694 (-16.3%), from €126,906 to €106,212

Income statement
  • Gross operating margin -€18,076

    down €18,076 (-18.5%), from €97,922 to €79,847

  • Other operating charges -€2,348

    down €2,348 (-59.7%), from €3,933 to €1,585

  • Staff costs +€1,999

    up €1,999 (+4.3%), from €46,674 to €48,673

  • Depreciation -€1,390

    down €1,390 (-3.3%), from €41,820 to €40,430

  • Financial charges -€1,170

    down €1,170 (-10.9%), from €10,690 to €9,520

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€5,617
Gross operating margin -€18,076
Staff costs -€1,999
Depreciation +€1,390
Other operating charges +€2,348
Financial income -€550
Financial charges +€1,170
Taxes +€640
Result 2025 -€20,694
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€29,549
Investment -€4,956
Financing -€29,688
Cash 2024 €57,002
Net result for the year -€20,694
Depreciation +€40,430
Stocks and contracts -€22,610
Receivables within one year +€30,059
Deferred charges and accrued income +€710
Trade debts +€1,529
Tax, wage and social debts -€278
Other debts +€404
Investment in fixed assets (net) -€4,956
Debts after one year -€32,771
Current portion of long-term debt +€3,083
Cash 2025 €51,906
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €648,470 €599,741 -€48,728 -7.5%
Fixed assets 21/28 €489,841 €454,367 -€35,474 -7.2%
Intangible fixed assets 21 €435 €255 -€180 -41.3%
Tangible fixed assets 22/27 €488,756 €453,462 -€35,294 -7.2%
Land and buildings 22 €417,589 €400,359 -€17,231 -4.1%
Plant, machinery and equipment 23 €14,134 €10,256 -€3,879 -27.4%
Furniture and vehicles 24 €57,032 €42,847 -€14,185 -24.9%
Financial fixed assets 28 €650 €650 = 0.0%
Current assets 29/58 €158,629 €145,374 -€13,255 -8.4%
Stocks and contracts in progress 3 €44,689 €67,299 +€22,610 +50.6%
Stocks 30/36 €44,689 €67,299 +€22,610 +50.6%
Amounts receivable within one year 40/41 €53,146 €23,086 -€30,059 -56.6%
Trade receivables 40 €53,146 €23,086 -€30,059 -56.6%
Cash at bank and in hand 54/58 €57,002 €51,906 -€5,095 -8.9%
Deferred charges and accrued income 490/1 €3,793 €3,083 -€710 -18.7%
Total equity and liabilities 10/49 €648,470 €599,741 -€48,728 -7.5%
Equity 10/15 €173,149 €152,455 -€20,694 -12.0%
Contributions 10/11 €25,000 €25,000 = 0.0%
Reserves 13 €21,243 €21,243 = 0.0%
Non-distributable reserves 130/1 €2,500 €2,500 = 0.0%
Reserves not available under the articles 1311 €2,500 €2,500 = 0.0%
Tax-exempt reserves 132 €18,743 €18,743 = 0.0%
Profit (loss) carried forward 14 €126,906 €106,212 -€20,694 -16.3%
Amounts payable 17/49 €475,321 €447,287 -€28,034 -5.9%
Amounts payable after more than one year 17 €336,754 €303,983 -€32,771 -9.7%
Financial debts 170/4 €336,754 €303,983 -€32,771 -9.7%
Amounts payable within one year 42/48 €138,566 €143,303 +€4,737 +3.4%
Current portion of amounts payable after more than one year 42 €30,786 €33,869 +€3,083 +10.0%
Trade debts 44 €9,831 €11,360 +€1,529 +15.6%
Suppliers 440/4 €9,831 €11,360 +€1,529 +15.6%
Taxes, remuneration and social security 45 €29,363 €29,085 -€278 -0.9%
Taxes 450/3 €17,299 €15,753 -€1,545 -8.9%
Remuneration and social security 454/9 €12,065 €13,332 +€1,267 +10.5%
Other amounts payable 47/48 €68,586 €68,990 +€404 +0.6%
Remuneration, social security and pensions 62 €46,674 €48,673 +€1,999 +4.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €41,820 €40,430 -€1,390 -3.3%
Other operating charges 640/8 €3,933 €1,585 -€2,348 -59.7%
Gross operating margin 9900 €97,922 €79,847 -€18,076 -18.5%
Operating profit (loss) 9901 €5,496 -€10,842 -€16,337
Financial income 75/76B €890 €340 -€550 -61.8%
Recurring financial income 75 €890 €340 -€550 -61.8%
Financial charges 65/66B €10,690 €9,520 -€1,170 -10.9%
Recurring financial charges 65 €10,690 €9,520 -€1,170 -10.9%
Profit (loss) for the period before taxes 9903 -€4,304 -€20,021 -€15,717 -365%
Income taxes 67/77 €1,313 €673 -€640 -48.7%
Profit (loss) for the period 9904 -€5,617 -€20,694 -€15,077 -268%
Profit (loss) for the period to be appropriated 9905 -€5,617 -€20,694 -€15,077 -268%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.